GlaxoSmithKline Pharmaceuticals’ promoter plan to increase stake: Report

31 May 2013 Evaluate

GlaxoSmithKline Pharmaceuticals’ promoter is reportedly planning to increase stake in the company. The parent company will hike the stake through voluntary open offer. The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.17% and 15.16% in the company, respectively.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2400.00 30.15 (1.27%)
14-Jan-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1695.80
Dr. Reddys Lab 1186.75
Cipla 1429.40
Zydus Lifesciences 884.35
Lupin 2196.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×